Literature DB >> 11859397

Comparison of short tandem repeat and variable number tandem repeat genetic markers for quantitative determination of allogeneic bone marrow transplant engraftment.

S A Schichman1, P Suess, A M Vertino, P S Gray.   

Abstract

Variable number tandem repeats (VNTRs) were among the first genetic markers used to quantitate bone marrow transplant engraftment. The limitations of PCR-based VNTR markers in distinguishing some donor/recipient pairs has shown the need for additional genetic markers to analyze engraftment. Short tandem repeats (STRs) provide an excellent tool for this purpose because of their high degree of polymorphism and relatively short length. We compared STR analysis results with previous VNTR results for 16 post-transplantation samples from four allogeneic bone marrow transplant patients. Previously analyzed patient samples were chosen to cover the full range of engraftment. DNA samples from each patient were analyzed in a blinded fashion. Good quantitative correlation was found between STR and VNTR results in samples from all four patients. STR markers were informative in one patient for whom PCR-based VNTR markers were not available. Correlation of VNTR and STR methods helps to validate the use of STRs for the quantitative analysis of bone marrow transplant engraftment. This study demonstrates that STR-based human identity testing kits are well suited for engraftment analysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11859397     DOI: 10.1038/sj.bmt.1703360

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  20 in total

1.  Double unrelated reduced-intensity umbilical cord blood transplantation in adults.

Authors:  Karen K Ballen; Thomas R Spitzer; Beow Y Yeap; Steven McAfee; Bimalangshu R Dey; Eyal Attar; Richard Haspel; Grace Kao; Deborah Liney; Edwin Alyea; Stephanie Lee; Corey Cutler; Vincent Ho; Robert Soiffer; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2007-01       Impact factor: 5.742

2.  Quantifying the relative amount of mouse and human DNA in cancer xenografts using species-specific variation in gene length.

Authors:  Ming-Tseh Lin; Li-Hui Tseng; Hirohiko Kamiyama; Mihoko Kamiyama; Phillip Lim; Manuel Hidalgo; Sarah Wheelan; James Eshleman
Journal:  Biotechniques       Date:  2010-03       Impact factor: 1.993

3.  Systematic analysis of interference due to stutter in estimating chimerism following hematopoietic cell transplantation.

Authors:  Bharat Thyagarajan; Shawn Young; Stacy Floodman; Randolph Peterson; Xinjing Wang
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

4.  Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial.

Authors:  Patrice Chevallier; Myriam Labopin; Gérard Socié; Reza Tabrizi; Sabine Furst; Bruno Lioure; Thierry Guillaume; Jacques Delaunay; Régis Peffault de La Tour; Stéphane Vigouroux; Jean El-Cheikh; Didier Blaise; Mauricette Michallet; Karin Bilger; Noel Milpied; Philippe Moreau; Mohamad Mohty
Journal:  Haematologica       Date:  2014-06-20       Impact factor: 9.941

5.  Quantitative tools for assessing the fate of xenotransplanted human stem/progenitor cells in chimeric mice.

Authors:  Kang Cheng; Sanjeev Gupta
Journal:  Xenotransplantation       Date:  2009 May-Jun       Impact factor: 3.907

6.  Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 Antibody, Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-2, and Haploidentical Natural Killer Cells.

Authors:  Aimee C Talleur; Brandon M Triplett; Sara Federico; Ewelina Mamcarz; William Janssen; Jianrong Wu; David Shook; Wing Leung; Wayne L Furman
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-18       Impact factor: 5.742

7.  Bone marrow transplant engraftment analysis with loss of an informative allele.

Authors:  Steven A Schichman; Pei Lin; Lori J Gilbrech; Pamela S Gray; Carla S Wilson; Jeffrey R Sawyer
Journal:  J Mol Diagn       Date:  2002-11       Impact factor: 5.568

8.  Bone marrow engraftment analysis after granulocyte transfusion.

Authors:  Sharon L Swierczynski; Michael J Hafez; Juliet Philips; Meghan A Higman; Karin D Berg; Kathleen M Murphy
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

9.  NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia.

Authors:  Jeffrey E Rubnitz; Hiroto Inaba; Raul C Ribeiro; Stanley Pounds; Barbara Rooney; Teresa Bell; Ching-Hon Pui; Wing Leung
Journal:  J Clin Oncol       Date:  2010-01-19       Impact factor: 44.544

10.  Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.

Authors:  Navneet S Majhail; Claudio G Brunstein; Marcie Tomblyn; Avis J Thomas; Jeffrey S Miller; Mukta Arora; Dan S Kaufman; Linda J Burns; Arne Slungaard; Philip B McGlave; John E Wagner; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2008-03       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.